Zealand Pharma A/s buy BiotechBee
Start price
01.10.24
/
70%
€109.30
Target price
31.12.27
€150.00
Performance (%)
-2.47%
End price
14.12.24
€106.60
Summary
This prediction ended on 14.12.24 with a price of €106.60. With a performance of -2.47%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Zealand Pharma A/s | -2.307% | -2.307% | -40.816% |
| iShares Core DAX® | -3,99 % | -2,81 % | 4,16 % |
| iShares Nasdaq 100 | 0,35 % | -0,75 % | 9,47 % |
| iShares Nikkei 225® | -3,85 % | 4,23 % | 28,36 % |
| iShares S&P 500 | 0,30 % | 0,38 % | 6,14 % |
According to BiotechBee what are the pros and cons of Zealand Pharma A/s for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Zealand Pharma A/s diskutieren
Buy mit Kursziel 150,0